Bio Preservation Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product {Equipment (Freezers, Refrigerators, Consumables), Media (Pre-formulated, Home-brew), LIMS}, By Application {Regenerative Medicine (Cell therapy, Gene therapy, Others), Bio-banking (Human eggs, Human sperms, Veterinary IVF), Drug Discovery}, By Region and Competition, 2020-2030F

Market Overview

The Global Bio Preservation Market, valued at USD 2.10 Billion in 2024, is projected to experience a CAGR of 9.90% to reach USD 3.70 Billion by 2030. Biopreservation refers to methods designed to maintain the viability and functionality of biological samples, including cells, tissues, and organs, outside their native environment for prolonged periods. This market growth is primarily supported by the escalating demand for organ transplants and the expanding scope of regenerative medicine research. The increasing establishment of biobanks globally also serves as a key driver. According to the U. S. Department of Health and Human Services, in 2023, the U. S. government invested approximately $2.3 billion in health research, encompassing biopreservation technologies.

Further market propulsion stems from rising investments in life science research and the increasing prevalence of chronic diseases, necessitating advanced preservation solutions for personalized medicine. Illustratively, data from the EU Horizon 2020 framework revealed over €500 million in funding disbursed for innovative health technologies, including biopreservation solutions, in 2023. A significant challenge impeding market expansion is the substantial cost associated with advanced biopreservation techniques and specialized equipment.

Key Market Drivers

Advancements in regenerative medicine and cell and gene therapies represent a significant driver for the global biopreservation market, necessitating sophisticated methods to preserve delicate biological materials. The expansion of these therapeutic areas, offering novel treatments for previously intractable diseases, directly fuels the demand for high-quality preservation and storage solutions for cells, tissues, and genetic constructs. These innovative therapies rely heavily on maintaining the viability and integrity of living cells from research to clinical application. According to the Alliance for Regenerative Medicine, in 2024, investments in the cell and gene therapy sector reached $15.2 billion, demonstrating a 30% growth compared to 2023. This substantial financial commitment underscores the escalating pipeline of therapies requiring robust biopreservation infrastructure.

The global biopreservation market also experiences considerable impetus from ongoing technological advancements in biopreservation methods and equipment. Innovations in cryopreservation techniques, including optimized cryoprotective agents and controlled-rate freezing equipment, enhance the efficacy and safety of preserving sensitive biological samples. These technological strides minimize cellular damage during freezing and thawing, improving post-preservation viability for clinical and research applications. For example, according to the BMC Molecular and Cell Biology journal, in September 2024, human dermal fibroblasts cryopreserved under optimized conditions for 1 and 3 months exhibited cell viability exceeding 80% upon revival. Such improvements are vital given the increasing scale of biopreservation needs across various medical fields. Additionally, the broader biopreservation market is significantly impacted by critical applications like organ transplantation, where maintaining organ viability before transplant is paramount. According to the International Report on Organ Donation and Transplantation Activities by the World Health Organization, in December 2024, global solid organ transplants increased by 9.5% compared to 2022, totaling 172,397 transplants worldwide.

Download Free Sample Report

Key Market Challenges

The challenging factor explicitly identified in the overview is the substantial cost associated with advanced biopreservation techniques and specialized equipment. This significant financial burden directly impedes the growth of the Global Bio Preservation Market by presenting considerable barriers to both initial setup and sustained operation for many organizations. The high cost encompasses the acquisition of specialized equipment, such as ultra-low temperature freezers and advanced cryopreservation systems, along with recurring expenses for liquid nitrogen, cryoprotective agents, and highly skilled personnel. Such extensive investment demands often exceed the budgetary allocations of smaller research institutions, emerging biobanks, and even some larger entities.

This economic strain consequently restricts the widespread implementation of advanced biopreservation solutions across the industry. For example, according to an iSpecimen online questionnaire of global biobanks in March 2023, 64 percent of participating biobanks identified economic sustainability as a major or moderate challenge. This highlights that a substantial segment of the market's fundamental infrastructure providers faces difficulties in managing the financial aspects of their preservation activities. As a direct result, the market experiences slowed adoption of new technologies and reduced expansion of existing preservation capacities, thereby hampering overall market growth.

Key Market Trends

The integration of Artificial Intelligence (AI) is a pivotal trend transforming the Global Bio Preservation Market by optimizing complex processes and enhancing sample integrity. AI algorithms analyze extensive datasets from cryopreservation protocols and post-preservation viability, identifying optimal conditions and predicting outcomes, thereby refining preservation methodologies. For instance, according to The University of Manchester, in September 2024, scientists developing a machine learning program for cryoprotectant discovery reduced the amount of conventional cryoprotectant required for blood storage by introducing newly identified molecules. This demonstrates AI's direct impact on improving preservation techniques. A May 2025 report by the National Association of Manufacturers indicated that 51% of manufacturers already employ AI, with 61% anticipating increased investment by 2027. This substantial adoption highlights AI's growing role in advancing biopreservation.

The expanding use of organ-on-chip systems and organoids presents a significant trend, necessitating advanced biopreservation solutions for these complex three-dimensional models. These intricate constructs are vital for drug discovery, disease modeling, and regenerative medicine, requiring robust preservation for their structural and functional integrity during storage and transport. Key innovations in 2024 included the refinement of culture protocols for generating more physiologically relevant organoids derived from a wide range of human tissues, coupled with the integration of microfluidics and biomaterial scaffolds to enhance organ-specific microenvironments. The broader life sciences sector, encompassing organoid research, reflects substantial financial commitment. In the first half of 2025, the BioIndustry Association reported the UK's life sciences sector attracted £1.23 billion in venture capital investment. This underpins innovation in biotechnologies, including advanced models dependent on effective biopreservation.

Segmental Insights

The Media segment is experiencing rapid expansion within the Global Bio Preservation Market, primarily driven by the escalating demand for advanced and optimized preservation solutions. This growth stems from significant advancements in regenerative medicine, cell and gene therapies, and expanding biobanking activities, all of which necessitate superior maintenance of biological sample viability and functionality during storage. The critical role of specialized media in minimizing cellular damage and ensuring biological integrity, alongside the increasing need to adhere to stringent quality and regulatory frameworks for clinical and research applications, underpins its accelerated market penetration and development.

Regional Insights

North America stands as the dominant region in the global bio preservation market, driven by a confluence of influential factors. The region benefits significantly from continuous advancements in biomedical research and the ongoing development of advanced therapeutic approaches. A substantial prevalence of chronic diseases further fuels the demand for sophisticated biopreservation techniques essential for diagnostics and treatment applications. Robust government support, including funding from institutions such as the National Institutes of Health (NIH) and the National Cancer Institute (NCI), actively promotes biobanking initiatives and research efforts. This comprehensive ecosystem encourages the widespread adoption of innovative biopreservation technologies by healthcare providers and biotechnology firms for critical regenerative medicine and personalized healthcare solutions.

Recent Developments

• In September 2025, Thermo Fisher Scientific introduced a next-generation ultra-low temperature storage system. This new product was designed to enhance long-term sample stability for biobanks and research laboratories. The system addresses a critical need for reliable temperature control within the global bio preservation market, ensuring the integrity of diverse biological specimens. This innovative launch supports advanced research and therapeutic applications, contributing to the efficient and secure storage of valuable biological materials for extended periods. It underscores the company's commitment to providing sophisticated solutions for scientific advancements.

• In August 2025, BioLife Solutions expanded its CryoStor portfolio by introducing optimized preservation solutions specifically formulated for cell and gene therapies. These new solutions are crucial for maintaining the viability and functionality of delicate cellular materials throughout cryopreservation and subsequent transport, which are essential processes within the global bio preservation market. The development aims to mitigate cellular damage and improve recovery rates post-thaw, thereby supporting the accelerating pace of research and commercialization in advanced therapeutic fields and ensuring higher quality biological samples.

• In November 2024, Oxford Nanopore Technologies collaborated with UK Biobank to develop a large-scale epigenetic dataset. This partnership involved sequencing 50,000 samples using advanced DNA/RNA technology, representing a significant effort in understanding disease mechanisms and advancing personalized treatments. The initiative supports breakthrough healthcare by providing comprehensive epigenome insights, directly impacting the long-term preservation and analysis strategies critical for future developments within the global bio preservation market. This collaboration highlights efforts to enhance the utility of stored biological samples.

• In August 2024, Thermo Fisher Scientific opened a new clinical and commercial ultra-cold storage facility in Bleiswijk, Netherlands. This expansion directly addressed the increasing demand for ultra-cold storage solutions, particularly vital for advanced therapies like cell and gene therapies within the European clinical trial network. The facility enhances the existing infrastructure for secure and long-term biological sample preservation, playing a crucial role in the global bio preservation market by ensuring the integrity and availability of critical materials for ongoing research and clinical applications.

Key Market Players

• BioCision LLC
• BioLife Solutions Inc.
• ThermoGenesis Holdings, Inc.
• Custom Biogenic Systems Inc.
• Lifeline Scientific Inc.
• Merck KGaA
• Princeton CryoTech Inc.
• VWR International, LLC
• Azenta US Inc.
• Koninklijke DSM N.V.

Report Scope:

In this report, the Global Bio Preservation Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Bio Preservation Market, By Product:

o   Equipment

o   Media

o   LIMS

• Bio Preservation Market, By Application:

o   Regenerative Medicine

o   Bio-banking

o   Drug Discovery

• Bio Preservation Market, By Region:

o   North America

§  United States

§  Canada

§  Mexico

o   Europe

§  France

§  United Kingdom

§  Italy

§  Germany

§  Spain

o   Asia Pacific

§  China

§  India

§  Japan

§  Australia

§  South Korea

o   South America

§  Brazil

§  Argentina

§  Colombia

o   Middle East & Africa

§  South Africa

§  Saudi Arabia

§  UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Bio Preservation Market.

Available Customizations:

Global Bio Preservation Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Global Bio Preservation Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]